Join
Loncar China BioPharma ETF logo

CHNA

NASDAQ

Loncar China BioPharma ETF

Sectorn/aIndustryn/aIPOn/a
$14.28-0.08 (-0.56%)
News0/Ratings0

The investment seeks to track the performance, before fees and expenses, of the Loncar China BioPharma Index (the index). Under normal circumstances, at least 80% of the fund's total assets (exclusive of any collateral held from securities lending) will be invested in the component securities of the index or in depositary receipts representing such component securities. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries. The fund is non-diversified.

Latest news

0 items

No recent news.

CHNA FAQ

6 questions
  • What does Loncar China BioPharma ETF do?
    The investment seeks to track the performance, before fees and expenses, of the Loncar China BioPharma Index (the index). Under normal circumstances, at least 80% of the fund's total assets (exclusive of any collateral held from securities lending) will be invested in the component securities of the index or in depositary receipts representing such component securities. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries. The fund is non-diversified.
  • Where does CHNA stock trade?
    Loncar China BioPharma ETF (CHNA) is listed on NASDAQ.
  • What sector and industry is CHNA in?
    Loncar China BioPharma ETF operates in the n/a sector.
  • When did Loncar China BioPharma ETF go public?
    Loncar China BioPharma ETF (CHNA) completed its IPO in n/a.
  • What companies are similar to CHNA?
    Notable peers in the same industry include CBOE (Cboe Global Markets, Inc.), HCXY (Hercules Capital, Inc.), PCI (PIMCO Dynamic Credit and Mortgage Income Fund), BXS (BancorpSouth Bank), AJAX (Ajax I). Compare CHNA side-by-side with any of them on Quantisnow.
  • How can I track CHNA on Quantisnow?
    Quantisnow aggregates Loncar China BioPharma ETF's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CHNA to receive live email and push alerts on every new disclosure.